Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01464840 · ClinicalTrials.gov registry record
The Pharmacokinetics of Azithromycin Prophylaxis for Cesarean Delivery
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 30
- Enrollment target
NCT01464840 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 30 participants.
The verdict
NCT01464840 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
PKAZ is a single institution study designed to evaluate the optimal dosing parameters for azithromycin for pre-surgical cesarean prophylaxis. Hypothesis: Pre-operative administration of azithromycin results in maternal and neonatal tissue concentrations that adequately treat microbes commonly involved in post-cesarean infections.
Interventions
- DRUG Azithromycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2011-11 |
| Est. Completion | 2013-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01464840
The ClinicalTrials.gov registry entry for NCT01464840 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Azithromycin is the first listed.
NCT01464840 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01464840 about?
NCT01464840 is a clinical study titled "The Pharmacokinetics of Azithromycin Prophylaxis for Cesarean Delivery". PKAZ is a single institution study designed to evaluate the optimal dosing parameters for azithromycin for pre-surgical cesarean prophylaxis. Hypothesis: Pre-operative administration of azithromycin results in maternal and neonatal tissue concentrations that adequately treat microbes commonly invol...
What is the current status of trial NCT01464840?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2011-11. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01464840?
The interventions under investigation include: Azithromycin (DRUG).
Who is sponsoring clinical trial NCT01464840?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.